Solid Biosciences gets FDA okay for DMD trial

Solid Biosciences (SLDB) gets FDA okay for clinical testing of DMD gene therapy. (00:26) Chevron (CVX) reviewing options for Texas Haynesville shale assets - Reuters. (02:01) U.S. House clears stopgap spending bill to avoid government shutdown, Senate vote next. (02:53) Episode transcripts seekingalpha.com/wsb.Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.Show links: Biggest stock movers today: JD.com, Arcturus Therapeutics and moreChina reset? Big business, Biden set to meet with Xi JinpingWall Street’s 20 most overbought stocksC3.ai soars on expansion of AWS deal focused on generative AI